Santé log

Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1

In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete lesion healing compared with 20% receiving investigator’s ...
Santé log

Curaechoice and Fast Pace Health Partner to Expand Affordable Healthcare Access Across Multiple States

Curaechoice members now have enhanced access to covered services at over 300 Fast Pace Health clinics at $0 cost. Birmingham, ALABAMA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Curaechoic ...
Santé log

The Integrated Healthcare Association Recognizes California Provider Organizations for Medicare Advantage Performance

OAKLAND, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Integrated Healthcare Association (IHA) today announced top-performing provider organizations and those demonstrating the greatest year-over-year ...
Santé log

Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution

To report a suspected adverse event related to DESMODA, contact Eton Pharmaceuticals, Inc. at 1-855-224-0233 or the U.S. Food and Drug Administration (FDA) at https://www.fda.gov/safety/medwatch or ...
Santé log

RAMSAY SANTE : Half-year results at the end of December 2025

Half-year results at the end of December 2025. Quality offering driving revenue growth, with continued efficiency supporting operational ...
Santé log

SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic

SPARK NS will release a Call for Proposals for the 2027 Cohort of the program in March 2026. For the 2027 Cohort, SPARK NS will accept applications from principal investigators in the US, Canada, UK, ...
Santé log

Sharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana Ecosystem

Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class, smart-safety syringe products to the healthcare industry. The Company’s product ...
Santé log

Baba Emerges from Stealth with Over $6.5 Million in Seed Funding to Expand Medicare-Covered Patient Advocacy for Older Adults

The capital will support the continued expansion of Baba's Medicare-covered advocacy services, deepen partnerships with providers and health systems, and advance its long-term mission to make ...
Santé log

AIM ImmunoTech Announces Extension of Subscription Period of its Previously Announced Rights Offering to March 3, 2026

AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic ...
Santé log

Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11

Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or ...
Santé log

Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell

Increasing doses of laromestrocel are associated with decreases in soluble (degraded) tyrosine kinase with immunoglobulin and epidermal growth factor homology domains (TIE-2), the cognate receptor for ...
Santé log

Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year

Revenue Growth – Precipio’s revenues increased from $18.5M in 2024 to $24.0M in 2025, an increase of 30% year over year. Q4-2025 revenues were $6.7M, an increase of 23% YoY from $5.4M in Q4-2024.